Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes have?
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes has 35 citations in the OpenAlex counts ScholarIQ stores.
When was Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes published?
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes has 2021 year in the ScholarIQ index.
What is the open-access status of Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes?
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes has bronze oa status in the ScholarIQ index.
What is the DOI of Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes?
The DOI for Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes is on the source record.
What is the PMID of Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes?
The PMID for Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes is on the source record.
What is the OpenAlex record for Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes?
The OpenAlex for Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes is on the source record.